4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-112385
Chief Development Officer sold 10,000 shares at $46.28 ($462,800)
- Chief Development Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2024-10-01 | Option exercise 10b5-1 | +10,000 | $21.65 | $216,500 | 15,796 | D |
| Guyer William Chief Development Officer | 2024-10-01 | Sale 10b5-1 | −10,000 | $46.28 | $462,800 | 5,796 | D |
| Derivatives | |||||||
| Guyer William Chief Development Officer | 2024-10-01 | Option exercise · Stock option (right to buy) 10b5-1 | −10,000 | 460,000 | D | ||
| Open-market sales · 10,000 sh · avg $46.28 · $462,800 | |||||||
Loading xslF345X05/ownership.xml…